Sorafenib treatment of Asian patients with advanced renal cell carcinoma (RCC) in daily practice: Subset analysis of the large non-interventional PREDICT study.
Dingwei Ye
No relevant relationships to disclose
Jun Guo
No relevant relationships to disclose
Jae-Lyun Lee
Honoraria - Bayer; Novartis; Pfizer; Sanofi
Ai-Ping Zhou
No relevant relationships to disclose
Yiran Huang
No relevant relationships to disclose
Zhiquan Hu
No relevant relationships to disclose
Cheng Fu
No relevant relationships to disclose
Jiyan Liu
No relevant relationships to disclose
Lin Qi
No relevant relationships to disclose
Hanzhong Li
No relevant relationships to disclose
Qing Zou
No relevant relationships to disclose
Sung Joon Hong
Consultant or Advisory Role - Astellas Pharma
Honoraria - Astellas Pharma
Kathrin Stauch
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Annette Böckenhoff
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Gyunji Kim
Employment or Leadership Position - Bayer; Bayer
XiaoJing Zhang
Employment or Leadership Position - Bayer
Hanjong Ahn
No relevant relationships to disclose
Jianhui Ma
No relevant relationships to disclose